OPC-67683: Clinical Trials

1 trial of OPC-67683, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow OPC-67683: new trials by email Literature Review of OPC-67683 trials Research Report on OPC-67683

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China
Delamanid - Multidrug Resistant Tuberculosis
Phase 4UnknownBeijing Chest Hospital6082020-07-162022-07-07

Conditions studied

Tuberculosis, Multidrug-Resistant (1)

Sponsors

Beijing Chest Hospital (1)

Countries

China (1)

Top investigators

Liang Li (1)

Results publications

PMID 41090140, PMID 41419836